Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$6.30
-0.8%
C$6.29
C$5.09
C$6.55
C$627.81M0.21924565,079 shs43,465 shs
HEXO Corp. stock logo
HEXO
HEXO
$0.71
+2.5%
$0.87
$0.66
$3.84
$31.24M1.35880,508 shs305,500 shs
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
C$5.60
-0.2%
C$5.15
C$3.00
C$5.75
C$175.81M0.65083912,654 shs4,300 shs
Organigram Global Inc. stock logo
OGI
Organigram Global
$1.76
+2.9%
$1.53
$0.85
$2.00
$235.93M1.49728,986 shs522,744 shs
Zomedica Corp. stock logo
ZOM
Zomedica
$0.12
$0.09
$0.16
$95.35M1.034.72 million shs790,936 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
+0.16%-1.55%+2.09%+4.61%+6.19%
HEXO Corp. stock logo
HEXO
HEXO
0.00%0.00%0.00%0.00%0.00%
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
+0.36%+0.72%+10.65%+12.88%+72.09%
Organigram Global Inc. stock logo
OGI
Organigram Global
+3.01%+4.27%+19.58%+24.82%-8.06%
Zomedica Corp. stock logo
ZOM
Zomedica
0.00%0.00%0.00%0.00%-26.19%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$6.30
-0.8%
C$6.29
C$5.09
C$6.55
C$627.81M0.21924565,079 shs43,465 shs
HEXO Corp. stock logo
HEXO
HEXO
$0.71
+2.5%
$0.87
$0.66
$3.84
$31.24M1.35880,508 shs305,500 shs
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
C$5.60
-0.2%
C$5.15
C$3.00
C$5.75
C$175.81M0.65083912,654 shs4,300 shs
Organigram Global Inc. stock logo
OGI
Organigram Global
$1.76
+2.9%
$1.53
$0.85
$2.00
$235.93M1.49728,986 shs522,744 shs
Zomedica Corp. stock logo
ZOM
Zomedica
$0.12
$0.09
$0.16
$95.35M1.034.72 million shs790,936 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
+0.16%-1.55%+2.09%+4.61%+6.19%
HEXO Corp. stock logo
HEXO
HEXO
0.00%0.00%0.00%0.00%0.00%
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
+0.36%+0.72%+10.65%+12.88%+72.09%
Organigram Global Inc. stock logo
OGI
Organigram Global
+3.01%+4.27%+19.58%+24.82%-8.06%
Zomedica Corp. stock logo
ZOM
Zomedica
0.00%0.00%0.00%0.00%-26.19%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
3.33
BuyC$7.1513.31% Upside
HEXO Corp. stock logo
HEXO
HEXO
0.00
N/AN/AN/A
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
2.00
HoldC$5.00-10.55% Downside
Organigram Global Inc. stock logo
OGI
Organigram Global
0.00
N/AN/AN/A
Zomedica Corp. stock logo
ZOM
Zomedica
4.00
Strong BuyN/AN/A

Current Analyst Ratings Breakdown

Latest HEXO, ZOM, OGI, GUD, and HLS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/21/2025
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHoldModerate BuyC$5.00 ➝ C$6.00
(Data available from 9/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$384.56M1.64C$1.64 per share3.85C$7.65 per share0.82
HEXO Corp. stock logo
HEXO
HEXO
$146.20M0.21N/AN/A$2.44 per share0.29
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
C$56.42M3.11C$0.37 per share15.22C$2.51 per share2.22
Organigram Global Inc. stock logo
OGI
Organigram Global
$223.82M1.04N/AN/A$2.07 per share0.84
Zomedica Corp. stock logo
ZOM
Zomedica
$25.19M0.00N/AN/A$0.24 per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
-C$30.73MN/AN/AN/A-8.81%-4.04%0.51%N/A
HEXO Corp. stock logo
HEXO
HEXO
-$845.90M-$5.21N/AN/AN/A-235.33%-74.04%-32.51%N/A
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
-C$15.53M-C$0.48N/AN/A-38.70%-25.27%-2.89%N/A
Organigram Global Inc. stock logo
OGI
Organigram Global
-$33.39M$0.0534.71N/AN/A2.86%-8.19%-5.79%N/A
Zomedica Corp. stock logo
ZOM
Zomedica
-$34.53M-$0.06N/AN/AN/A-232.88%-12.47%-11.84%N/A

Latest HEXO, ZOM, OGI, GUD, and HLS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2025Q3 2025
Organigram Global Inc. stock logo
OGI
Organigram Global
-$0.01-$0.03-$0.02-$0.03$68.04 million$50.49 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
N/AN/AN/AN/AN/A
HEXO Corp. stock logo
HEXO
HEXO
N/AN/AN/AN/AN/A
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
N/A4.30%N/AN/AN/A
Organigram Global Inc. stock logo
OGI
Organigram Global
N/AN/AN/AN/AN/A
Zomedica Corp. stock logo
ZOM
Zomedica
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
7.52
3.36
1.79
HEXO Corp. stock logo
HEXO
HEXO
0.01
0.41
0.24
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
86.50
1.56
1.01
Organigram Global Inc. stock logo
OGI
Organigram Global
N/A
2.59
1.42
Zomedica Corp. stock logo
ZOM
Zomedica
N/A
10.82
10.15

Institutional Ownership

CompanyInstitutional Ownership
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
16.33%
HEXO Corp. stock logo
HEXO
HEXO
7.78%
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
0.42%
Organigram Global Inc. stock logo
OGI
Organigram Global
34.63%
Zomedica Corp. stock logo
ZOM
Zomedica
8.95%

Insider Ownership

CompanyInsider Ownership
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
45.62%
HEXO Corp. stock logo
HEXO
HEXO
4.69%
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
0.37%
Organigram Global Inc. stock logo
OGI
Organigram Global
0.09%
Zomedica Corp. stock logo
ZOM
Zomedica
4.19%
CompanyEmployeesShares OutstandingFree FloatOptionable
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
72599.65 millionN/ANot Optionable
HEXO Corp. stock logo
HEXO
HEXO
1,27744.00 million41.93 millionOptionable
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
9131.39 millionN/ANot Optionable
Organigram Global Inc. stock logo
OGI
Organigram Global
860134.05 million133.93 millionOptionable
Zomedica Corp. stock logo
ZOM
Zomedica
50979.95 million938.89 millionNot Optionable

Recent News About These Companies

15 Cheapest Stocks Insiders Are Buying In March
Q4 2024 Zomedica Corp Earnings Call
Zomedica Corp. (ZOMDF) Q4 2024 Earnings Call Transcript
Zomedica (ZOMDF) Gets a Buy from Noble Financial
Zomedica Corp.

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Knight Therapeutics stock logo

Knight Therapeutics TSE:GUD

C$6.30 -0.05 (-0.79%)
As of 04:00 PM Eastern

Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.

HEXO stock logo

HEXO NYSE:HEXO

HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. It has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada. As of June 22, 2023, HEXO Corp. operates as a subsidiary of Tilray Brands, Inc.

HLS Therapeutics stock logo

HLS Therapeutics TSE:HLS

C$5.60 -0.01 (-0.18%)
As of 03:41 PM Eastern

HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company products include Clozaril, Absorica, Vascepa, CSAN Pronto, Trinomia and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States and the Rest of the world.

Organigram Global stock logo

Organigram Global NASDAQ:OGI

$1.76 +0.05 (+2.92%)
Closing price 04:00 PM Eastern
Extended Trading
$1.74 -0.01 (-0.85%)
As of 06:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.

Zomedica stock logo

Zomedica NYSEAMERICAN:ZOM

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy. The company has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for the development of a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. is headquartered in Ann Arbor, Michigan.